The role of microbiome: a novel insight into urolithiasis

References

• Allison MJ, Dawson KA, Mayberry WR, Foss JG. 1985. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol. 141(1):1–7.
   PubMed Web of Science ®Google Scholar
• Amimanan P, Tavichakorntrakool R, Fong-Ngern K, Sribenjalux P, Lulitanond A, Prasongwatana V, Wongkham C, Boonsiri P, Umka Welbat J, Thongboonkerd V. 2017. Elongation factor Tu on Escherichia coli isolated from urine of kidney stone patients promotes calcium oxalate crystal growth and aggregation. Sci Rep. 7(1):2953.
   PubMedGoogle Scholar
• Andrade-Oliveira V, Amano MT, Correa-Costa M, Castoldi A, Felizardo RJ, de Almeida DC, Bassi EJ, Moraes-Vieira PM, Hiyane MI, Rodas AC, et al. 2015. Gut bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol. 26(8):1877–1888.
   PubMed Web of Science ®Google Scholar
• Antonelli JA, Maalouf NM, Pearle MS, Lotan Y. 2014. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol. 66(4):724–729.
   PubMed Web of Science ®Google Scholar
• Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E, Del Moral JS, Gómez-Millán J, Yucel G, Lara MF. 2018. The urinary tract microbiome in health and disease. Eur Urol Focus. 4(1):128–138.
   PubMedGoogle Scholar
• Arvans D, Jung YC, Antonopoulos D, Koval J, Granja I, Bashir M, Karrar E, Roy-Chowdhury J, Musch M, Asplin J, et al. 2017. Oxalobacter formigenes-derived bioactive factors stimulate oxalate transport by intestinal epithelial cells. J Am Soc Nephrol. 28(3):876–887.
   PubMed Web of Science ®Google Scholar
• Barr-Beare E, Saxena V, Hilt EE, Thomas-White K, Schober M, Li B, Becknell B, Hains DS, Wolfe AJ, Schwaderer AL. 2015. The interaction between enterobacteriaceae and calcium oxalate deposits. PLoS One. 10(10):e0139575.
   PubMed Web of Science ®Google Scholar
• Batagello CA, Monga M, Miller AW. 2018. Calcium oxalate urolithiasis: a case of missing microbes? J Endourol. 32(11):995–1005.
   PubMed Web of Science ®Google Scholar
• Benoit M, Desnues B, Mege JL. 2008. Macrophage polarization in bacterial infections. J Immunol. 181(6):3733–3739.
   PubMed Web of Science ®Google Scholar
• Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S. 2002. Urinary infection stones. Int J Antimicrob Agents. 19(6):488–498.
   PubMed Web of Science ®Google Scholar
• Biehl LM, Cruz Aguilar R, Farowski F, Hahn W, Nowag A, Wisplinghoff H, Vehreschild M. 2018. Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection. Infection. 46(6):871–874.
   PubMed Web of Science ®Google Scholar
• Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI, Knight R, Mills DA, Caporaso JG. 2013. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 10(1):57–59.
   PubMed Web of Science ®Google Scholar
• Borghi L, Guerra A, Meschi T, Briganti A, Schianchi T, Allegri F, Novarini A. 1999. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers. Kidney Int. 55(3):1041–1050.
   PubMed Web of Science ®Google Scholar
• Boyan-Salyers BD, Boskey AL. 1980. Relationship between proteolipids and calcium-phospholipid-phosphate complexes in Bacterionema matruchotii calcification. Calcif Tissue Int. 30(2):167–174.
   PubMed Web of Science ®Google Scholar
• Brain E, Geraghty RM, Cook P, Roderick P, Somani B. 2021. Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years. World J Urol. 39(8):3095–3101.
   PubMed Web of Science ®Google Scholar
• Bukin YS, Galachyants YP, Morozov IV, Bukin SV, Zakharenko AS, Zemskaya TI. 2019. The effect of 16S rRNA region choice on bacterial community metabarcoding results. Sci Data. 6:190007.
   PubMed Web of Science ®Google Scholar
• Callahan BJ, McMurdie PJ, Holmes SP. 2017. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis. Isme J. 11(12):2639–2643.
   PubMed Web of Science ®Google Scholar
• Callahan BJ, Wong J, Heiner C, Oh S, Theriot CM, Gulati AS, McGill SK, Dougherty MK. 2019. High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution. Nucleic Acids Res. 47(18):e103.
   PubMed Web of Science ®Google Scholar
• Cangelosi GA, Meschke JS. 2014. Dead or alive: molecular assessment of microbial viability. Appl Environ Microbiol. 80(19):5884–5891.
   PubMed Web of Science ®Google Scholar
• Chen D, Jiang C, Liang X, Zhong F, Huang J, Lin Y, Zhao Z, Duan X, Zeng G, Wu W. 2019. Early and rapid prediction of postoperative infections following percutaneous nephrolithotomy in patients with complex kidney stones. BJU Int. 123(6):1041–1047.
   PubMed Web of Science ®Google Scholar
• Chen F, Bao X, Liu S, Ye K, Xiang S, Yu L, Xu Q, Zhang Y, Wang X, Zhu X, et al. 2021. Gut microbiota affect the formation of calcium oxalate renal calculi caused by high daily tea consumption. Appl Microbiol Biotechnol. 105(2):789–802.
   PubMed Web of Science ®Google Scholar
• Cherng JH, Hsu YJ, Liu CC, Tang SH, Sartika D, Chang SJ, Fan GY, Wu ST, Meng E. 2019. Activities of Ca2+-related ion channels during the formation of kidney stones in an infection-induced urolithiasis rat model. Am J Physiol Renal Physiol. 317(5):F1342–f1349.
   PubMed Web of Science ®Google Scholar
• Chewcharat A, Curhan G. 2021. Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis. 49(1):27–39.
   PubMed Web of Science ®Google Scholar
• Chung WS, Walker AW, Louis P, Parkhill J, Vermeiren J, Bosscher D, Duncan SH, Flint HJ. 2016. Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC Biol. 14:3.
   PubMed Web of Science ®Google Scholar
• Chutipongtanate S, Sutthimethakorn S, Chiangjong W, Thongboonkerd V. 2013. Bacteria can promote calcium oxalate crystal growth and aggregation. J Biol Inorg Chem. 18(3):299–308.
   PubMed Web of Science ®Google Scholar
• Cumpanas AA, Bratu OG, Bardan RT, Ferician OC, Cumpanas AD, Horhat FG, Licker M, Pricop C, Cretu OM. 2020. Urinary microbiota-are we ready for prime time? A literature review of study methods’ critical steps in avoiding contamination and minimizing biased results. Diagnostics (Basel). 10(6):343.
   PubMedGoogle Scholar
• Curhan GC, Willett WC, Speizer FE, Stampfer MJ. 2001. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 59(6):2290–2298.
   PubMed Web of Science ®Google Scholar
• Daudon M, Frochot V, Bazin D, Jungers P. 2018. Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs. 78(2):163–201.
   PubMed Web of Science ®Google Scholar
• D'Costa MR, Haley WE, Mara KC, Enders FT, Vrtiska TJ, Pais VM, Jacobsen SJ, McCollough CH, Lieske JC, Rule AD. 2019. Symptomatic and radiographic manifestations of kidney stone recurrence and their prediction by risk factors: a prospective cohort study. J Am Soc Nephrol. 30(7):1251–1260.
   PubMed Web of Science ®Google Scholar
• De Ferrari ME, Macaluso M, Brunati C, Pozzoli R, Colussi G. 1996. Hypocitraturia and Ureaplasma urealyticum urinary tract infection in patients with idiopathic calcium nephrolithiasis. Nephrol Dial Transplant. 11(6):1185.
   PubMed Web of Science ®Google Scholar
• Denburg MR, Koepsell K, Lee JJ, Gerber J, Bittinger K, Tasian GE. 2020. Perturbations of the gut microbiome and metabolome in children with calcium oxalate kidney stone disease. J Am Soc Nephrol. 31(6):1358–1369.
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6(11):e280.
   PubMed Web of Science ®Google Scholar
• Djojodimedjo T, Soebadi DM. Soetjipto   2013. Escherichia coli infection induces mucosal damage and expression of proteins promoting urinary stone formation. Urolithiasis. 41:295–301.
   PubMed Web of Science ®Google Scholar
• Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W. 2006. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis. 48(4):546–554.
   PubMed Web of Science ®Google Scholar
• Dornbier RA, Bajic P, Van Kuiken M, Jardaneh A, Lin H, Gao X, Knudsen B, Dong Q, Wolfe AJ, Schwaderer AL. 2020. The microbiome of calcium-based urinary stones. Urolithiasis. 48(3):191–199.
   PubMed Web of Science ®Google Scholar
• Dubnau D, Smith I, Morell P, Marmur J. 1965. Gene conservation in Bacillus species. I. Conserved genetic and nucleic acid base sequence homologies. Proc Natl Acad Sci USA. 54(2):491–498.
   PubMed Web of Science ®Google Scholar
• Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS. 2002. Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol. 68(8):3841–3847.
   PubMed Web of Science ®Google Scholar
• Edgar RC. 2018. Updating the 97% identity threshold for 16S ribosomal RNA OTUs. Bioinformatics. 34(14):2371–2375.
   PubMed Web of Science ®Google Scholar
• Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. 2003. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 111(5):607–616.
   PubMed Web of Science ®Google Scholar
• Ferraro PM, Curhan GC, Gambaro G, Taylor EN. 2019. Antibiotic use and risk of incident kidney stones in female nurses. Am J Kidney Dis. 74(6):736–741.
   PubMed Web of Science ®Google Scholar
• Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. 2014. Gut microbiota and metabolic syndrome. World J Gastroenterol. 20(43):16079–16094.
   PubMed Web of Science ®Google Scholar
• Fihn SD. 2003. Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med. 349(3):259–266.
   PubMed Web of Science ®Google Scholar
• Finlayson B. 1978. Physicochemical aspects of urolithiasis. Kidney Int. 13(5):344–360.
   PubMed Web of Science ®Google Scholar
• Flannigan R, Choy WH, Chew B, Lange D. 2014. Renal struvite stones-pathogenesis, microbiology, and management strategies. Nat Rev Urol. 11(6):333–341.
   PubMed Web of Science ®Google Scholar
• Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, et al. 2012. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 10:174.
   PubMed Web of Science ®Google Scholar
• Griffith DP. 1982. Infection-induced renal calculi. Kidney Int. 21(2):422–430.
   PubMed Web of Science ®Google Scholar
• Groah SL, Rounds AK, Ljungberg IH, Sprague BM, Frost JK, Tractenberg RE. 2019. Intravesical Lactobacillus rhamnosus GG is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: first-in-human trial. Ther Adv Urol. 11:1756287219875594.
   Web of Science ®Google Scholar
• Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW. 2006. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int. 69(4):691–698.
   PubMed Web of Science ®Google Scholar
• Hatch M. 2020. Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6. Urolithiasis. 48(1):1–8.
   PubMed Web of Science ®Google Scholar
• Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, Brubaker L, Gai X, Wolfe AJ, Schreckenberger PC. 2014. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 52(3):871–876.
   PubMed Web of Science ®Google Scholar
• Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschênes G, Unwin R, Milliner D. 2011. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant. 26(11):3609–3615.
   PubMed Web of Science ®Google Scholar
• Hoppe B, Niaudet P, Salomon R, Harambat J, Hulton SA, Van't Hoff W, Moochhala SH, Deschênes G, Lindner E, Sjögren A, et al. 2017. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Pediatr Nephrol. 32(5):781–790.
   PubMed Web of Science ®Google Scholar
• Jairath A, Parekh N, Otano N, Mishra S, Ganpule A, Sabnis R, Desai M. 2015. Oxalobacter formigenes: opening the door to probiotic therapy for the treatment of hyperoxaluria. Scand J Urol. 49(4):334–337.
   PubMed Web of Science ®Google Scholar
• Jeong IG, Kang T, Bang JK, Park J, Kim W, Hwang SS, Kim HK, Park HK. 2011. Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis. 58(3):383–388.
   PubMed Web of Science ®Google Scholar
• Ji J, Shu D, Zheng M, Wang J, Luo C, Wang Y, Guo F, Zou X, Lv X, Li Y, et al. 2016. Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci Rep. 6:24838.
   PubMed Web of Science ®Google Scholar
• Jiang S, Lu S, Chen X, Li F, Zhu C, Zheng Y, Wang X, Xu S. 2021. Dysbiosis of urine microbiota in obstructive urinary retention patients revealed by next-generation sequencing. Ann Clin Microbiol Antimicrob. 20(1):2.
   PubMed Web of Science ®Google Scholar
• Kachroo N, Lange D, Penniston KL, Stern J, Tasian G, Bajic P, Wolfe AJ, Suryavanshi M, Ticinesi A, Meschi T, et al. 2021. Standardization of microbiome studies for urolithiasis: an international consensus agreement. Nat Rev Urol. 18(5):303–311.
   PubMed Web of Science ®Google Scholar
• Kaneko K, Kobayashi R, Yasuda M, Izumi Y, Yamanobe T, Shimizu T. 2012. Comparison of matrix proteins in different types of urinary stone by proteomic analysis using liquid chromatography-tandem mass spectrometry. Int J Urol. 19(8):765–772.
   PubMed Web of Science ®Google Scholar
• Kanlaya R, Naruepantawart O, Thongboonkerd V. 2019. Flagellum is responsible for promoting effects of viable Escherichia coli on calcium oxalate crystallization, crystal growth, and crystal aggregation. Front Microbiol. 10:2507.
   PubMed Web of Science ®Google Scholar
• Karstens L, Asquith M, Caruso V, Rosenbaum JT, Fair DA, Braun J, Gregory WT, Nardos R, McWeeney SK. 2018. Community profiling of the urinary microbiota: considerations for low-biomass samples. Nat Rev Urol. 15(12):735–749.
   PubMed Web of Science ®Google Scholar
• Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR. 2008. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol. 19(6):1197–1203.
   PubMed Web of Science ®Google Scholar
• Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW. 2011. Factors related to colonization with Oxalobacter formigenes in U.S. adults. J Endourol. 25(4):673–679.
   PubMed Web of Science ®Google Scholar
• Khan SR, Canales BK, Dominguez-Gutierrez PR. 2021. Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol. 17(6):417–433.
   PubMed Web of Science ®Google Scholar
• Khan SR. 2013. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol. 189(3):803–811.
   PubMed Web of Science ®Google Scholar
• Kharlamb V, Schelker J, Francois F, Jiang J, Holmes RP, Goldfarb DS. 2011. Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol. 25(11):1781–1785.
   PubMed Web of Science ®Google Scholar
• Kumar R, Ghoshal UC, Singh G, Mittal RD. 2004. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation. J Gastroenterol Hepatol. 19(12):1403–1409.
   PubMed Web of Science ®Google Scholar
• Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD. 2002. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol. 41(3):318–322.
   PubMed Web of Science ®Google Scholar
• Kwak C, Jeong BC, Lee JH, Kim HK, Kim EC, Kim HH. 2001. Molecular identification of Oxalobacter formigenes with the polymerase chain reaction in fresh or frozen fecal samples. BJU Int. 88(6):627–632.
   PubMed Web of Science ®Google Scholar
• Lagier JC, Dubourg G, Million M, Cadoret F, Bilen M, Fenollar F, Levasseur A, Rolain JM, Fournier PE, Raoult D. 2018. Culturing the human microbiota and culturomics. Nat Rev Microbiol. 16:540–550.
   PubMed Web of Science ®Google Scholar
• Lange JN, Wood KD, Wong H, Otto R, Mufarrij PW, Knight J, Akpinar H, Holmes RP, Assimos DG. 2012. Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. Urology. 79(6):1286–1289.
   PubMed Web of Science ®Google Scholar
• Lewis DA, Brown R, Williams J, White P, Jacobson SK, Marchesi JR, Drake MJ. 2013. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol. 3:41.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al. 2017. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 5(1):14.
   PubMed Web of Science ®Google Scholar
• Li L, Ma L, Fu P. 2017. Gut microbiota-derived short-chain fatty acids and kidney diseases. Drug Des Devel Ther. 11:3531–3542.
   PubMed Web of Science ®Google Scholar
• Lieske JC, de la Vega LS, Gettman MT, Slezak JM, Bergstralh EJ, Melton LJ, 3rd, Leibson CL. 2006. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis. 48(6):897–904.
   PubMed Web of Science ®Google Scholar
• Lin D, Peters BA, Friedlander C, Freiman HJ, Goedert JJ, Sinha R, Miller G, Bernstein MA, Hayes RB, Ahn J. 2018. Association of dietary fibre intake and gut microbiota in adults. Br J Nutr. 120(9):1014–1022.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang N, Jiang P, Zhai Q, Li C, Yu D, Wu Y, Zhang Y, Lv L, Xu X, et al. 2020. Characteristics of the urinary microbiome in kidney stone patients with hypertension. J Transl Med. 18(1):130.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang N, Wu Y, Jiang P, Jiang T, Wang Y, Zhang Y, Zhai Q, Zou Y, Feng N. 2020. The pelvis urinary microbiome in patients with kidney stones and clinical associations. BMC Microbiol. 20(1):336.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jin X, Hong HG, Xiang L, Jiang Q, Ma Y, Chen Z, Cheng L, Jian Z, Wei Z, et al. 2020. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease. FASEB J. 34(8):11200–11214.
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Ravel J. 2015. The vocabulary of microbiome research: a proposal. Microbiome. 3:31.
   PubMed Web of Science ®Google Scholar
• Markowski MC, Boorjian SA, Burton JP, Hahn NM, Ingersoll MA, Maleki Vareki S, Pal SK, Sfanos KS. 2019. The microbiome and genitourinary cancer: a collaborative review. Eur Urol. 75(4):637–646.
   PubMed Web of Science ®Google Scholar
• Martinez-Guryn K, Leone V, Chang EB. 2019. Regional diversity of the gastrointestinal microbiome. Cell Host Microbe. 26(3):314–324.
   PubMed Web of Science ®Google Scholar
• Maruvada P, Leone V, Kaplan LM, Chang EB. 2017. The human microbiome and obesity: moving beyond associations. Cell Host Microbe. 22(5):589–599.
   PubMed Web of Science ®Google Scholar
• McLean RJ, Nickel JC, Cheng KJ, Costerton JW. 1988. The ecology and pathogenicity of urease-producing bacteria in the urinary tract. Crit Rev Microbiol. 16(1):37–79.
   PubMed Web of Science ®Google Scholar
• Merchant ML, Cummins TD, Wilkey DW, Salyer SA, Powell DW, Klein JB, Lederer ED. 2008. Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol. 295(4):F1254–F1258.
   PubMed Web of Science ®Google Scholar
• Meschi T, Nouvenne A, Ticinesi A, Prati B, Guerra A, Allegri F, Pigna F, Soldati L, Vezzoli G, Gambaro G, et al. 2012. Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J Transl Med. 10(1):63.
   PubMedGoogle Scholar
• Miller AW, Choy D, Penniston KL, Lange D. 2019. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis. Kidney Int. 96(1):180–188.
   PubMed Web of Science ®Google Scholar
• Miller AW, Oakeson KF, Dale C, Dearing MD. 2016. Microbial community transplant results in increased and long-term oxalate degradation. Microb Ecol. 72(2):470–478.
   PubMed Web of Science ®Google Scholar
• Miller AW, Orr T, Dearing D, Monga M. 2019. Loss of function dysbiosis associated with antibiotics and high fat, high sugar diet. Isme J. 13(6):1379–1390.
   PubMed Web of Science ®Google Scholar
• Miller EA, Beasley DE, Dunn RR, Archie EA. 2016. Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique? Front Microbiol. 7:1936.
   PubMed Web of Science ®Google Scholar
• Miller NL, Gillen DL, Williams JC, Jr., Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE. 2009. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque. BJU Int. 103(7):966–971.
   PubMed Web of Science ®Google Scholar
• Milliner D, Hoppe B, Groothoff J. 2018. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Urolithiasis. 46(4):313–323.
   PubMed Web of Science ®Google Scholar
• Mittal RD, Kumar R, Bid HK, Mittal B. 2005. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol. 19(1):102–106.
   PubMed Web of Science ®Google Scholar
• Mobley HL, Island MD, Hausinger RP. 1995. Molecular biology of microbial ureases. Microbiol Rev. 59(3):451–480.
   PubMedGoogle Scholar
• Mu C, Yang Y, Luo Z, Guan L, Zhu W. 2016. The colonic microbiome and epithelial transcriptome are altered in rats fed a high-protein diet compared with a normal-protein diet. J Nutr. 146(3):474–483.
   PubMed Web of Science ®Google Scholar
• Nazzal L, Francois F, Henderson N, Liu M, Li H, Koh H, Wang C, Gao Z, Perez GP, Asplin JR, et al. 2021. Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretion. Sci Rep. 11(1):16428.
   PubMed Web of Science ®Google Scholar
• Neugent ML, Hulyalkar NV, Nguyen VH, Zimmern PE, De Nisco NJ. 2020. Advances in understanding the human urinary microbiome and its potential role in urinary tract infection. mBio. 11(2):e00218–20.
   PubMed Web of Science ®Google Scholar
• Nguyen NP, Warnow T, Pop M, White B. 2016. A perspective on 16S rRNA operational taxonomic unit clustering using sequence similarity. NPJ Biofilms Microbiomes. 2:16004.
   PubMed Web of Science ®Google Scholar
• Ning Y, Yang G, Chen Y, Zhao X, Qian H, Liu Y, Chen S, Shi G. 2020. Characteristics of the urinary microbiome from patients with gout: a prospective study. Front Endocrinol (Lausanne). 11:272.
   PubMed Web of Science ®Google Scholar
• Norsworthy AN, Pearson MM. 2017. From catheter to kidney stone: the uropathogenic lifestyle of Proteus mirabilis. Trends Microbiol. 25(4):304–315.
   PubMed Web of Science ®Google Scholar
• Obligado SH, Goldfarb DS. 2008. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 21(3):257–264.
   PubMed Web of Science ®Google Scholar
• Ooijevaar RE, Terveer EM, Verspaget HW, Kuijper EJ, Keller JJ. 2019. Clinical application and potential of fecal microbiota transplantation. Annu Rev Med. 70:335–351.
   PubMed Web of Science ®Google Scholar
• Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, Kliethermes S, Schreckenberger PC, Brubaker L, Gai X, et al. 2014. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 5(4):e01283–e01214.
   PubMed Web of Science ®Google Scholar
• Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, et al. 2009. The NIH Human Microbiome Project. Genome Res. 19(12):2317–2323.
   PubMed Web of Science ®Google Scholar
• Price TK, Dune T, Hilt EE, Thomas-White KJ, Kliethermes S, Brincat C, Brubaker L, Wolfe AJ, Mueller ER, Schreckenberger PC. 2016. The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms. J Clin Microbiol. 54(5):1216–1222.
   PubMed Web of Science ®Google Scholar
• Price TK, Hilt EE, Thomas-White K, Mueller ER, Wolfe AJ, Brubaker L. 2020. The urobiome of continent adult women: a cross-sectional study. BJOG. 127(2):193–201.
   PubMed Web of Science ®Google Scholar
• Randall A. 1937. The origin and growth of renal calculi. Ann Surg. 105(6):1009–1027.
   PubMedGoogle Scholar
• Reid G, Bruce AW. 2006. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol. 24(1):28–32.
   PubMed Web of Science ®Google Scholar
• Salem N, Salem L, Saber S, Ismail G, Bluth MH. 2015. Corynebacterium urealyticum: a comprehensive review of an understated organism. Infect Drug Resist. 8:129–145.
   PubMed Web of Science ®Google Scholar
• Schloss PD, Gevers D, Westcott SL. 2011. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One. 6(12):e27310.
   PubMed Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. 2016. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14(8):e1002533.
   PubMed Web of Science ®Google Scholar
• Shiekh FA, Charlesworth JE, Kim SH, Hunter LW, Jayachandran M, Miller VM, Lieske JC. 2010. Proteomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries. Acta Biomater. 6(10):4065–4072.
   PubMed Web of Science ®Google Scholar
• Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS. 2011. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 11(1):244.
   PubMedGoogle Scholar
• Sidhu H, Hoppe B, Hesse A, Tenbrock K, Brömme S, Rietschel E, Peck AB. 1998. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet. 352(9133):1026–1029.
   PubMed Web of Science ®Google Scholar
• Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB. 1999. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol. 10(14):S334–S340.
   PubMedGoogle Scholar
• Singh P, Enders FT, Vaughan LE, Bergstralh EJ, Knoedler JJ, Krambeck AE, Lieske JC, Rule AD. 2015. Stone composition among first-time symptomatic kidney stone formers in the community. Mayo Clin Proc. 90(10):1356–1365.
   PubMed Web of Science ®Google Scholar
• Sorensen MD, Kahn AJ, Reiner AP, Tseng TY, Shikany JM, Wallace RB, Chi T, Wactawski-Wende J, Jackson RD, O’Sullivan MJ, et al. 2012. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol. 187(5):1645–1649.
   PubMed Web of Science ®Google Scholar
• Soriano F, Ponte C, Santamaría M, Castilla C, Fernández Roblas R. 1986. In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum). J Clin Microbiol. 23(4):691–694.
   PubMed Web of Science ®Google Scholar
• Soriano F, Tauch A. 2008. Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. Clin Microbiol Infect. 14(7):632–643.
   PubMed Web of Science ®Google Scholar
• Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. 2017. Epidemiology of stone disease across the world. World J Urol. 35(9):1301–1320.
   PubMed Web of Science ®Google Scholar
• Spiljar M, Merkler D, Trajkovski M. 2017. The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs. Front Immunol. 8:1353.
   PubMed Web of Science ®Google Scholar
• Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, Yarova-Yarovaya Y, Fiedler T, Cox M, Stamm WE. 2011. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 52(10):1212–1217.
   PubMed Web of Science ®Google Scholar
• Stern JM, Moazami S, Qiu Y, Kurland I, Chen Z, Agalliu I, Burk R, Davies KP. 2016. Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers. Urolithiasis. 44(5):399–407.
   PubMed Web of Science ®Google Scholar
• Stern JM, Urban-Maldonado M, Usyk M, Granja I, Schoenfeld D, Davies KP, Agalliu I, Asplin J, Burk R, Suadicani SO. 2019. Fecal transplant modifies urine chemistry risk factors for urinary stone disease. Physiol Rep. 7(4):e14012.
   PubMed Web of Science ®Google Scholar
• Suryavanshi MV, Bhute SS, Gune RP, Shouche YS. 2018. Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease. Sci Rep. 8(1):16598.
   PubMedGoogle Scholar
• Suryavanshi MV, Bhute SS, Jadhav SD, Bhatia MS, Gune RP, Shouche YS. 2016. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures. Sci Rep. 6:34712.
   PubMed Web of Science ®Google Scholar
• Taguchi K, Okada A, Unno R, Hamamoto S, Yasui T. 2021. Macrophage function in calcium oxalate kidney stone formation: a systematic review of literature. Front Immunol. 12:673690.
   PubMed Web of Science ®Google Scholar
• Tang R, Jiang Y, Tan A, Ye J, Xian X, Xie Y, Wang Q, Yao Z, Mo Z. 2018. 16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones. Urolithiasis. 46(6):503–514.
   PubMed Web of Science ®Google Scholar
• Tasian GE, Jemielita T, Goldfarb DS, Copelovitch L, Gerber JS, Wu Q, Denburg MR. 2018. Oral antibiotic exposure and kidney stone disease. J Am Soc Nephrol. 29(6):1731–1740.
   PubMed Web of Science ®Google Scholar
• Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A. 2020. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study. BJU Int. 125(1):133–143.
   PubMed Web of Science ®Google Scholar
• Tavichakorntrakool R, Boonsiri P, Prasongwatana V, Lulitanond A, Wongkham C, Thongboonkerd V. 2017. Differential colony size, cell length, and cellular proteome of Escherichia coli isolated from urine vs. stone nidus of kidney stone patients. Clin Chim Acta. 466:112–119.
   PubMed Web of Science ®Google Scholar
• Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, Saisud P, Sribenjalux P, Pimratana C, Bovornpadungkitti S, Sriboonlue P, Thongboonkerd V. 2012. Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrol Dial Transplant. 27(11):4125–4130.
   PubMed Web of Science ®Google Scholar
• Taylor EN, Stampfer MJ, Curhan GC. 2005a. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 68(3):1230–1235.
   PubMed Web of Science ®Google Scholar
• Taylor EN, Stampfer MJ, Curhan GC. 2005b. Obesity, weight gain, and the risk of kidney stones. Jama. 293(4):455–462.
   PubMed Web of Science ®Google Scholar
• Taylor EN, Stampfer MJ, Mount DB, Curhan GC. 2010. DASH-style diet and 24-hour urine composition. Clin J Am Soc Nephrol. 5(12):2315–2322.
   PubMed Web of Science ®Google Scholar
• Thongprayoon C, Krambeck AE, Rule AD. 2020. Determining the true burden of kidney stone disease. Nat Rev Nephrol. 16(12):736–746.
   PubMed Web of Science ®Google Scholar
• Ticinesi A, Milani C, Guerra A, Allegri F, Lauretani F, Nouvenne A, Mancabelli L, Lugli GA, Turroni F, Duranti S, et al. 2018. Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers. Gut. 67(12):2097–2106.
   PubMed Web of Science ®Google Scholar
• Ticinesi A, Nouvenne A, Chiussi G, Castaldo G, Guerra A, Meschi T. 2020. Calcium oxalate nephrolithiasis and gut microbiota: not just a gut-kidney axis. A nutritional perspective. Nutrients. 12(2):548.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. 2014. Microbiota and diabetes: an evolving relationship. Gut. 63(9):1513–1521.
   PubMed Web of Science ®Google Scholar
• Torzewska A, Budzyńska A, Białczak-Kokot M, Różalski A. 2014. In vitro studies of epithelium-associated crystallization caused by uropathogens during urinary calculi development. Microb Pathog. 71-72:25–31.
   PubMed Web of Science ®Google Scholar
• Torzewska A, Stączek P, Róźalski A. 2003. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides. J Med Microbiol. 52(Pt 6):471–477.
   PubMed Web of Science ®Google Scholar
• Troxel SA, Sidhu H, Kaul P, Low RK. 2003. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol. 17(3):173–176.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. 2007. The human microbiome project. Nature. 449(7164):804–810.
   PubMed Web of Science ®Google Scholar
• Van de Peer Y, Chapelle S, De Wachter R. 1996. A quantitative map of nucleotide substitution rates in bacterial rRNA. Nucleic Acids Res. 24(17):3381–3391.
   PubMed Web of Science ®Google Scholar
• van der Wijst J, van Goor MK, Schreuder MF, Hoenderop JG. 2019. TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis. Kidney Int. 96(6):1283–1291.
   PubMed Web of Science ®Google Scholar
• van Dijk S, Dean DD, Liu Y, Zhao Y, Chirgwin JM, Schwartz Z, Boyan BD. 1998. Purification, amino acid sequence, and cDNA sequence of a novel calcium-precipitating proteolipid involved in calcification of Corynebacterium matruchotii. Calcif Tissue Int. 62(4):350–358.
   PubMed Web of Science ®Google Scholar
• Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. 2015. The microbiome of the urinary tract-a role beyond infection. Nat Rev Urol. 12(2):81–90.
   PubMed Web of Science ®Google Scholar
• Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, Haase S, Mähler A, Balogh A, Markó L, et al. 2017. Salt-responsive gut commensal modulates TH17 axis and disease. Nature. 551(7682):585–589.
   PubMed Web of Science ®Google Scholar
• Woese CR, Fox GE, Zablen L, Uchida T, Bonen L, Pechman K, Lewis BJ, Stahl D. 1975. Conservation of primary structure in 16S ribosomal RNA. Nature. 254(5495):83–86.
   PubMed Web of Science ®Google Scholar
• Woese CR, Fox GE. 1977. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci USA. 74(11):5088–5090.
   PubMed Web of Science ®Google Scholar
• Woese CR, Kandler O, Wheelis ML. 1990. Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc Natl Acad Sci USA. 87(12):4576–4579.
   PubMed Web of Science ®Google Scholar
• Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, et al. 2012. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 50(4):1376–1383.
   PubMed Web of Science ®Google Scholar
• Xie J, Huang JS, Huang XJ, Peng JM, Yu Z, Yuan YQ, Xiao KF, Guo JN. 2020. Profiling the urinary microbiome in men with calcium-based kidney stones. BMC Microbiol. 20(1):41.
   PubMed Web of Science ®Google Scholar
• Xu R, Deebel N, Casals R, Dutta R, Mirzazadeh M. 2021. A new gold rush: a review of current and developing diagnostic tools for urinary tract infections. Diagnostics (Basel). 11(3):479.
   PubMedGoogle Scholar
• Yang B, Wang Y, Qian PY. 2016. Sensitivity and correlation of hypervariable regions in 16S rRNA genes in phylogenetic analysis. BMC Bioinformatics. 17:135.
   PubMed Web of Science ®Google Scholar
• Zampini A, Nguyen AH, Rose E, Monga M, Miller AW. 2019. Defining dysbiosis in patients with urolithiasis. Sci Rep. 9(1):5425.
   PubMedGoogle Scholar
• Zhao E, Zhang W, Geng B, You B, Wang W, Li X. 2020. Intestinal dysbacteriosis leads to kidney stone disease. Mol Med Rep. 23(3):180.
   PubMed Web of Science ®Google Scholar
• Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, LifeLines cohort study, et al. 2016. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 352(6285):565–569.
   PubMed Web of Science ®Google Scholar
• Zhou C, Li K, Zhao L, Li W, Guo Z, Xu J, Qi X, Yuan H. 2020. The relationship between urinary stones and Gut microbiomeby 16S sequencing. Biomed Res Int. 2020:1582187.
   PubMed Web of Science ®Google Scholar